Limitations in resectability of colorectal liver metastases 2020 - A systematic approach for clinicians and patients

Erik Schadde*, Dirk J Grunhagen, Cornelis Verhoef, Lucyna Krzywon, Peter Metrakos

*Corresponding author for this work

Research output: Contribution to journalReview articleAcademicpeer-review

15 Citations (Scopus)


Colorectal liver metastases (CRLM) affect over 50 % of all patients with colorectal cancer, which is the second leading cause of cancer in the western world. Resection of CRLM may provide cure and improves survival over chemotherapy alone. However, resectability of CLRM has to be decided in multidisciplinary tumor boards and is based on oncological factors, technical factors and patient factors. The advances of chemotherapy lead to the abolition of contraindications to resection in favor of technical resectability, but somatic mutations and molecular subtyping may improve selection of patients for resection in the future. Technical factors center around anatomy of the lesions, volume of the remnant liver and quality of the liver parenchymal. Multiple strategies have been developed to overcome volume limitations and they are reviewed here. The least investigated topic is how to select the right patients among an elderly and frail patient population for the large variety of technical options specifically for bi-lobar CRLM to keep 90-day mortality as low as possible. The review is an overview over the current state-of-the art and a systematic guide to the topic of resectability of CRLM for both clinicians and patients.

Original languageEnglish
Pages (from-to)10-20
Number of pages11
JournalSeminars in Cancer Biology
Publication statusPublished - Jun 2021

Bibliographical note

Copyright © 2020 Elsevier Ltd. All rights reserved.


Dive into the research topics of 'Limitations in resectability of colorectal liver metastases 2020 - A systematic approach for clinicians and patients'. Together they form a unique fingerprint.

Cite this